Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Theiler

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
The New England Journal of Medicine|January 18, 2023
Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1Jessica Miller, Nicole P Hachmann, Ai-Ris Y Collier, et al.
Biosensors|October 22, 2021
Optical Biosensor Platforms Display Varying Sensitivity for the Direct Detection of Influenza RNASamantha J Courtney, Zachary R Stromberg, Adán Myers Y Gutiérrez, et al.
Nature Medicine|June 24, 2003
Advantage of rare HLA supertype in HIV disease progressionElizabeth Trachtenberg, Bette Korber, Cristina Sollars, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2017
Antigenicity-defined conformations of an extremely neutralization-resistant HIV-1 envelope spikeYongfei Cai, Selen Karaca-Griffin, Jia Chen, et al.
Cell Host & Microbe|July 9, 2021
HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogensWill Fischer, Elena E Giorgi, Srirupa Chakraborty, et al.
PLOS Global Public Health|March 24, 2023
Fast Evaluation of Viral Emerging Risks (FEVER): A computational tool for biosurveillance, diagnostics, and mutation typing of emerging viral pathogensZachary R Stromberg, James Theiler, Brian T Foley, et al.
Journal of Virology|July 1, 2006
Cross-subtype T-cell immune responses induced by a human immunodeficiency virus type 1 group m consensus env immunogenEric A Weaver, Zhongjing Lu, Zenaido T Camacho, et al.
Cell Host & Microbe|March 11, 2021
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccinesXiaoying Shen, Haili Tang, Charlene McDanal, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
Contemporary HIV-1 envelope pseudovirus panels for detecting and assessing B cell lineages with broadly neutralizing antibody potentialBette Korber, Michael S Seaman, Nonhlanhla N Mkhize, et al.
Plos Pathogens|April 23, 2026
Contemporary HIV-1 envelope pseudovirus panels for detecting and assessing B cell lineages with broadly neutralizing antibody potentialBette Korber, Michael S Seaman, Nonhlanhla N Mkhize, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
The New England Journal of Medicine|January 18, 2023
Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1Jessica Miller, Nicole P Hachmann, Ai-Ris Y Collier, et al.
Biosensors|October 22, 2021
Optical Biosensor Platforms Display Varying Sensitivity for the Direct Detection of Influenza RNASamantha J Courtney, Zachary R Stromberg, Adán Myers Y Gutiérrez, et al.
Nature Medicine|June 24, 2003
Advantage of rare HLA supertype in HIV disease progressionElizabeth Trachtenberg, Bette Korber, Cristina Sollars, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2017
Antigenicity-defined conformations of an extremely neutralization-resistant HIV-1 envelope spikeYongfei Cai, Selen Karaca-Griffin, Jia Chen, et al.
Cell Host & Microbe|July 9, 2021
HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogensWill Fischer, Elena E Giorgi, Srirupa Chakraborty, et al.
PLOS Global Public Health|March 24, 2023
Fast Evaluation of Viral Emerging Risks (FEVER): A computational tool for biosurveillance, diagnostics, and mutation typing of emerging viral pathogensZachary R Stromberg, James Theiler, Brian T Foley, et al.
Journal of Virology|July 1, 2006
Cross-subtype T-cell immune responses induced by a human immunodeficiency virus type 1 group m consensus env immunogenEric A Weaver, Zhongjing Lu, Zenaido T Camacho, et al.
Cell Host & Microbe|March 11, 2021
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccinesXiaoying Shen, Haili Tang, Charlene McDanal, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
Contemporary HIV-1 envelope pseudovirus panels for detecting and assessing B cell lineages with broadly neutralizing antibody potentialBette Korber, Michael S Seaman, Nonhlanhla N Mkhize, et al.
Plos Pathogens|April 23, 2026
Contemporary HIV-1 envelope pseudovirus panels for detecting and assessing B cell lineages with broadly neutralizing antibody potentialBette Korber, Michael S Seaman, Nonhlanhla N Mkhize, et al.
Pageof 5